Your Cart (0)
Your cart is empty
Taxes included. Shipping and discounts are calculated at checkout.
Drawer menu
Taxes included. Shipping and discounts are calculated at checkout.
The mTOR kinase can be thought of as a central control system within the cell. It helps regulate metabolism, cell division, protein synthesis and cell growth. When this signaling pathway is dysregulated, normal cellular control may be disrupted. For example, inhibiting mTOR is being investigated as a way to restrict the growth of certain cancer cells. The pathway is also associated with metabolic conditions such as diabetes and obesity.
A study published in Science Translational Medicine in 2018 attracted considerable attention because it suggested that modulating mTOR activity may influence aspects of immune function and aging. Dysregulated mTOR signaling, by contrast, may contribute to impaired immunity, loss of muscle mass and the progression of age-related metabolic or neurological conditions.
Animal experiments involving worms, flies and mice have shown that reducing mTOR signaling can extend lifespan in certain models. These findings have made mTOR one of the most widely discussed pathways in longevity research. Results from animal models, however, cannot be transferred directly to humans.
A healthy body requires periods of mTOR activation. The pathway supports tissue growth, muscle protein synthesis and wound healing. Protein-rich meals and resistance exercise are among the factors that may activate mTOR.
For metabolic balance, periods of activation may alternate with periods of lower mTOR activity. Intermittent fasting and longer intervals without food are examples of lifestyle strategies that may temporarily reduce mTOR signaling.
mTOR can also be inhibited pharmacologically. Rapamycin, an immunosuppressive medicine, is one of the best-known examples. It is used medically in specific clinical situations and is being studied in aging research. However, mTOR inhibitors can cause significant adverse effects, including metabolic disturbances, high blood pressure, digestive problems and respiratory complications.
For this reason, prescription mTOR inhibitors should never be used solely for anti-aging purposes without specialist medical indication and supervision.
The desire to live longer—or even to overcome aging—has accompanied humanity for centuries. Modern research has identified mTOR as one of the critical signaling pathways involved in aging, nutrient sensing and cellular growth.
Natural changes in mTOR activity occur during fasting. When insulin and amino-acid signals fall, the mTOR complex becomes less active. Overnight fasting and structured eating windows may therefore create periods of lower mTOR activity.
Other factors discussed in connection with mTOR regulation include melatonin, vitamin D, alpha-lipoic acid and selected polyphenols. Evidence varies considerably, and these substances should not be regarded as direct substitutes for clinically studied interventions.
The goal is not to keep mTOR permanently switched off. Healthy tissue maintenance, muscle growth and recovery require mTOR activation. A balanced strategy may therefore combine resistance exercise and adequate protein intake with periods of fasting or lower energy intake.